1
|
Porteny T, Lynch M, Covaleski A, Tjia J, Gazarian P, Reich AJ, Perez S, Kennefick K, Weissman JS, Ladin K. Medical decision-making experiences of persons with dementia and their carepartners: a qualitative study. BMC Palliat Care 2025; 24:99. [PMID: 40205431 PMCID: PMC11983899 DOI: 10.1186/s12904-025-01710-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2024] [Accepted: 03/04/2025] [Indexed: 04/11/2025] Open
Abstract
BACKGROUND Persons with dementia (PWD) and their carepartners must often make complex medical decisions, weighing the benefits of medical (surgical and non-surgical) interventions with uncertainty regarding outcomes, both dementia- and non-dementia related, in the short-term and long-term. This study informs gaps in clinical guidance for patient-centered decision-making about medical and surgical interventions for PWD and advancecare planning. METHODS We conducted a qualitative study using thematic analysis based on semi-structured interviews with PWD and carepartners. RESULTS We interviewed 30 participants (9 PWD, 21 carepartners). Four themes were identified (with related subthemes): 1) PWD and carepartners varied in using decision-making approaches for medical interventions for PWD (a) variations in views about decision-making load; (b) Progressive involvement of carepartners in ACP decision-making as cognition erodes; 2) medical intervention decisions were an inflection point to evaluate values for dyads and involved tradeoffs with implications for end-of-life care and quality of life 3) lack of discussion with clinical team about impact of medical interventions on dementia burdened dyads; 4) decisional quality was facilitated by: (a) a trusting relationship with clinicians; and (b) a multidisciplinary team approach. CONCLUSION Most patients with mild-to-moderate dementia and carepartners approach medical intervention decision-making guided by their understanding of the dementia prognosis, but the risks of medical interventions are often unaddressed in discussions with the clinical team, sometimes burdening dyads with undesirable consequences to their quality-of-life. Clinicians should provide dementia-related risks regarding medical intervention outcomes to best facilitate decision-making conversations and advance care planning.
Collapse
Affiliation(s)
- Thalia Porteny
- Department of Health Policy and Management, Mailman School of Public Health, Columbia University, 722 West 168th St, New York, NY, 10035, USA.
| | - Mary Lynch
- Research on Ethics, Aging, and Health (REACH Lab), Tufts University, Medford, MA, USA
| | - Audrey Covaleski
- Research on Ethics, Aging, and Health (REACH Lab), Tufts University, Medford, MA, USA
| | | | | | - Amanda J Reich
- Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Stephen Perez
- Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA
| | - Kristen Kennefick
- Research on Ethics, Aging, and Health (REACH Lab), Tufts University, Medford, MA, USA
| | - Joel S Weissman
- Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Keren Ladin
- Research on Ethics, Aging, and Health (REACH Lab), Tufts University, Medford, MA, USA
- Department of Community Health, Tufts University, Medford, MA, USA
| |
Collapse
|
2
|
Gieselmann A, Gather J, Schmidt M, Qubad M, Vollmann J, Scholten M. Perspectives on advance research directives from individuals with mild cognitive impairment and family members: a qualitative interview study. Front Psychiatry 2024; 15:1419701. [PMID: 39371913 PMCID: PMC11450480 DOI: 10.3389/fpsyt.2024.1419701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Accepted: 08/26/2024] [Indexed: 10/08/2024] Open
Abstract
Background Advance research directives (ARDs) provide a promising way to involve individuals with mild cognitive impairment (MCI) in research decisions before they lose the capacity to consent. At the same time, the views of people with MCI on ARDs are underexplored. This study assesses the perceptions of people with MCI and family members on the benefits and challenges associated with ARDs. Aims The aim of this study was to investigate the perspectives of individuals with MCI and family members of individuals with MCI on ARDs. We focus specifically on willingness to participate in nontherapeutic research, understanding of ARDs and the ethical considerations involved. Methods Thirteen open-ended, face-to-face interviews were conducted using a semi-structured format. Seven interviews were conducted with individuals with MCI, and six with family members of individuals with MCI. The narratives were transcribed verbatim and qualitative content analysis was carried out. Results Research participation and ARDs were viewed positively, largely based on altruistic motives and the desire to contribute to society. The participants recognized the potential advantages of ARDs in reducing the decision-making burden on family members and maintaining personal autonomy. They also highlighted challenges in comprehending ARDs and navigating the complexities surrounding potential conflicts between current preferences versus preferences described in an ARD. Conclusions ARDs were predominantly seen as valuable instruments that enable individuals with MCI to participate in research. This study provides insights into the reasons why affected individuals are interested in drafting ARDs. These insights can guide the development of supportive interventions that are tailored to assist individuals with MCI and their families in navigating ARD processes.
Collapse
Affiliation(s)
- Astrid Gieselmann
- Ruhr University Bochum, Institute for Medical Ethics and History of Medicine, Bochum, Germany
- Charité – University Medicine Berlin, Department of Psychiatry and Psychotherapy, Berlin, Germany
| | - Jakov Gather
- Ruhr University Bochum, Institute for Medical Ethics and History of Medicine, Bochum, Germany
- Ruhr University Bochum, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Bochum, Germany
| | - Marina Schmidt
- Ruhr University Bochum, Institute for Medical Ethics and History of Medicine, Bochum, Germany
- Goethe University Frankurt/Main, Frankfurter Forum for Interdisciplinary Ageing Research (FFIA), Frankurt, Germany
| | - Mishal Qubad
- Goethe University Frankfurt/Main, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Frankurt, Germany
| | - Jochen Vollmann
- Ruhr University Bochum, Institute for Medical Ethics and History of Medicine, Bochum, Germany
| | - Matthé Scholten
- Ruhr University Bochum, Institute for Medical Ethics and History of Medicine, Bochum, Germany
| |
Collapse
|
3
|
Seidel K, Winiarski C, Thyrian JR, Haberstroh J. The psychological effects of research participation on people with dementia: findings from a German exploratory interview study. FRONTIERS IN DEMENTIA 2024; 3:1421541. [PMID: 39170731 PMCID: PMC11335729 DOI: 10.3389/frdem.2024.1421541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Accepted: 07/19/2024] [Indexed: 08/23/2024]
Abstract
The German National Dementia Strategy aims to engage people with dementia in research projects. However, the effects of such research participation on experience and behavior have been insufficiently explored. This study aimed to investigate the psychological effect of research participation on people living with dementia. In a qualitative, exploratory approach, guideline-based interviews were conducted with four persons with dementia who had served as co-researchers on an advisory board in a health services research study for 8 months at that time. The analysis revealed predominantly positive effects of research participation at all levels of experience and behavior. Most effects were reported by the co-researchers on a cognitive level. Both the perception of being competent and of making a positive contribution to oneself and/or others are key effects of research participation. The main effects on an emotional level were joy and wellbeing and on a behavioral level were positive social contacts and social communication. Sadness and insecurity represent the sole negative effects. Nuanced focal points of effects among the individual interviews were found. The results align with existing research highlighting the positive effects of participation on people with dementia. Through advancing an interdisciplinary perspective on their research involvement, we advocate for heightened attention to this topic within the realm of psychology.
Collapse
Affiliation(s)
- Katja Seidel
- Department of Psychology, Psychological Aging Research, Faculty V: School of Life Sciences, University of Siegen, Siegen, Germany
- German Center for Neurodegenerative Diseases (DZNE), Greifswald, Germany
| | - Claudia Winiarski
- Department of Psychology, Psychological Aging Research, Faculty V: School of Life Sciences, University of Siegen, Siegen, Germany
| | - Jochen René Thyrian
- German Center for Neurodegenerative Diseases (DZNE), Greifswald, Germany
- Institute for Community Medicine, University of Greifswald, Greifswald, Germany
| | - Julia Haberstroh
- Department of Psychology, Psychological Aging Research, Faculty V: School of Life Sciences, University of Siegen, Siegen, Germany
| |
Collapse
|
4
|
Badenhoop L, Baisch S, Penger S, Haberstroh J. The Role of Different Aspects of Communication Behavior in the Assessment of Capacity to Consent. GEROPSYCH 2023. [DOI: 10.1024/1662-9647/a000309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/08/2023]
Abstract
Abstract: Any medical treatment that interferes with physical integrity requires the informed consent of a patient capable of such consent. For people with dementia, the capacity to consent is questioned even in the early course of the disease. Particularly diagnostic instruments like the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) often deny people with dementia the capacity to consent because of high confounding of the results with patients’ verbal abilities. To date, it remains unclear whether not only verbal but also nonverbal communication is associated with assessments of capacity to consent. The current study investigates associations between patients’ verbal and nonverbal communication behaviors as assessed by the measure for Communication Behavior in People with Dementia in Ambulant Settings (CODEMamb) and capacity to consent as assessed by the MacCAT-T. We expected the strongest positive associations for verbal communication behaviors compared to nonverbal communication behaviors. Data of N = 43 patients with dementia ( n = 8 capable of consent) were collected at two different German psychiatric clinics. The results show small to moderate correlations between the overall scores of CODEMamb and MacCAT-T. As expected, correlations were strongest for the verbal CODEMamb subscale. The results support current findings on the dependency of the MacCAT-T on verbal communication. Based on the findings, the discussion addresses how people with dementia can be enabled to make self-determined medical treatment decisions.
Collapse
Affiliation(s)
- Luise Badenhoop
- Psychological Aging Research, Department of Psychology, Faculty V: School of Life Sciences, University of Siegen, Germany
| | - Stefanie Baisch
- Psychological Aging Research, Department of Psychology, Faculty V: School of Life Sciences, University of Siegen, Germany
| | - Susanne Penger
- Psychological Aging Research, Department of Psychology, Faculty V: School of Life Sciences, University of Siegen, Germany
| | - Julia Haberstroh
- Psychological Aging Research, Department of Psychology, Faculty V: School of Life Sciences, University of Siegen, Germany
| |
Collapse
|
5
|
Pauli P, Goetz K, Rogge A, Bartsch T, Philippen S, Berg D, Hertrampf K. Attitudes and Viewpoints Toward Prevention Trials in Alzheimer’s Disease. GEROPSYCH 2023. [DOI: 10.1024/1662-9647/a000311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/07/2023]
Abstract
Abstract: Alzheimer’s disease (AD) prevention studies use biomarkers to determine risk in asymptomatic study participants. This involves multifaceted implications. Determinants regarding participation in these trials are therefore of particular relevance. We used semistructured individual interviews to interview uninvolved persons ( n = 10), relatives of Alzheimer’s patients ( n = 10), and patients with mild cognitive impairment ( n = 5) and analyzed the interviews using qualitative content analysis according to Mayring. We discovered various factors to be positive motivations for participation; the most significant inhibiting factor was concern about negative psychological effects. These motivations and concerns should be specifically addressed in the study design of AD prevention trials. The fears and concerns expressed highlight the importance of a good methodological and ethical framework to increase participant acceptance.
Collapse
Affiliation(s)
- Philipp Pauli
- Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| | - Katja Goetz
- Institute of Family Medicine, University Hospital of Schleswig-Holstein, Campus Lübeck, Germany
| | - Annette Rogge
- Institute of Experimental Medicine, Biomedical Ethics, Christian Albrecht University Kiel, Germany
| | - Thorsten Bartsch
- Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| | - Sarah Philippen
- Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| | - Daniela Berg
- Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| | - Katrin Hertrampf
- Department of Oral and Maxillofacial Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| |
Collapse
|
6
|
Scholten M, Gather J, Vollmann J. Das kombinierte Modell der Entscheidungsassistenz. DER NERVENARZT 2022; 93:1093-1103. [PMID: 36121451 PMCID: PMC9630234 DOI: 10.1007/s00115-022-01384-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Accepted: 08/02/2022] [Indexed: 11/30/2022]
Abstract
Hintergrund Die Auslegung von Artikel 12 der Behindertenrechtskonvention der Vereinten Nationen (Art. 12 UN-BRK) durch den Ausschuss für die Rechte von Menschen mit Behinderungen hat zu einer Kontroverse über die Umsetzung des Artikels in der Psychiatrie geführt. Fragestellung Wie kann Art. 12 UN-BRK auf ethisch vertretbare Weise in der Psychiatrie umgesetzt werden? Material und Methode Es wurde eine empirisch und rechtlich informierte konzeptionelle und ethische Analyse durchgeführt. Ergebnisse Das vorgeschlagene kombinierte Modell der Entscheidungsassistenz gewährleistet die Anerkennung von Menschen mit psychischen Erkrankungen als Rechtssubjekt, deren Gleichbehandlung im Hinblick auf die Erteilung einer Einwilligung sowie die Bereitstellung von Entscheidungsassistenz. Nach diesem Modell dürfen Zwangsbehandlungen nur unter Achtung des Willens und der Präferenzen der Person und weiteren Voraussetzungen der Verhältnismäßigkeit und unabhängiger Überprüfung durchgeführt werden. Schlussfolgerungen Art. 12 UN-BRK kann nach dem kombinierten Modell der Entscheidungsassistenz auf ethisch vertretbare Weise in der Psychiatrie umgesetzt werden.
Collapse
Affiliation(s)
- Matthé Scholten
- Institut für Medizinische Ethik und Geschichte der Medizin, Ruhr-Universität Bochum, Markstr. 258a, 44799, Bochum, Deutschland.
| | - Jakov Gather
- Institut für Medizinische Ethik und Geschichte der Medizin, Ruhr-Universität Bochum, Markstr. 258a, 44799, Bochum, Deutschland
- Klinik für Psychiatrie, Psychotherapie und Präventivmedizin, LWL-Universitätsklinikum, Ruhr-Universität Bochum, Bochum, Deutschland
| | - Jochen Vollmann
- Institut für Medizinische Ethik und Geschichte der Medizin, Ruhr-Universität Bochum, Markstr. 258a, 44799, Bochum, Deutschland
| |
Collapse
|